Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer

Cancer Chemotherapy and Pharmacology

Volumn 63, Issue 6, 2009, Pages 1111-1119

  Chiarion Sileni, Vanna ^a   Innocente, Roberto ^b   Cavina, Raffaele ^c   Ruol, Alberto ^d   Corti, Luigi ^a   Pigozzo, Jacopo ^a   Del Bianco, Paola ^a   Fumagalli, Uberto ^c   Santoro, Armando ^c   Ancona, Ermanno ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Chemo radiotherapy; Esophageal cancer; Oxaliplatin; Phase II study

Indexed keywords

ANTIFUNGAL AGENT; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ADVANCED CANCER; AGED; ANASTOMOSIS LEAKAGE; ANEMIA; ARTICLE; ASPIRATION BIOPSY; ASPIRATION PNEUMONIA; ASTHENIA; BLOOD CELL COUNT; BLOOD CHEMISTRY; BLOOD TOXICITY; BONE MARROW TOXICITY; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIARRHEA; DIGESTIVE TRACT ENDOSCOPY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DYSPHAGIA; ENDOSCOPIC ECHOGRAPHY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FATALITY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION; LEUKOPENIA; LIVER TOXICITY; LUNG EDEMA; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NAUSEA; NEPHROTOXICITY; NEUROPATHY; NEUROTOXICITY; NEUTROPENIA; NEUTROPHIL COUNT; OVERALL SURVIVAL; PARESTHESIA; PATIENT COMPLIANCE; PERIOPERATIVE COMPLICATION; PHASE 2 CLINICAL TRIAL; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE FRACTIONATION; SEPSIS; SEPTICEMIA; SIDE EFFECT; SKIN TOXICITY; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; VEIN THROMBOSIS; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; KAPLAN-MEIERS ESTIMATE; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; ORGANOPLATINUM COMPOUNDS; RADIATION DOSAGE;

EID: 63949084961     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0834-3     Document Type: Article

References (41)

1. DJ Adelstein TW Rice LA Rybicki MA Larto J Ciezki J Saxton M DeCamp JJ Vargo JA Dumot G Zuccaro 2000 Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy J Clin Oncol 18 2032 2039
2. SE Al-Batran JT Hartmann S Probst H Schmalenberg S Hollerbach R Hofheinz V Rethwisch G Seipelt N Homann G Wilhelm G Schuch J Stoehlmacher HG Derigs S Hegewisch-Becker J Grossmann C Pauligk A Atmaca C Bokemeyer A Knuth E Jager 2008 Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie J Clin Oncol 26 1435 1442
3. E Ancona A Ruol S Santi S Merigliano VC Sileni H Koussis G Zaninotto L Bonavina A Peracchia 2001 Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophagal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone Cancer 91 2165 2174
4. C Aschele ML Friso S Pucciarelli S Lonardi L Sartor G Fabris ED Urso P Del Bianco G Sotti M Lise S Monfardini 2005 A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer Ann Oncol 16 1140 1146
5. SH Bailey DA Bull DH Harpole JJ Rentz LA Neumayer TN Pappas J Daley WG Henderson B Krasnicka SF Khuri 2003 Outcomes after esophagectomy: a ten-year prospective cohort Ann Thorac Surg 75 217 222 Discussion 222
6. L Bedenne P Michel O Bouche C Milan C Mariette T Conroy D Pezet B Roullet JF Seitz JP Herr B Paillot P Arveux F Bonnetain C Binquet 2007 Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102 J Clin Oncol 25 1160 1168
7. A Blackstock S Hess S Chancy J Tepper 1999 Oxaliplatin: in vitro evidence of its radiation sensitizing activity: pre-clinical observations relevant to clinical trials. Abstract 202 Int J Radiat Oncol Biol Phys 45 253 254
8. H Bleiberg T Conroy B Paillot AJ Lacave G Blijham JH Jacob L Bedenne M Namer P De Besi F Gay L Collette T Sahmoud 1997 Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer Eur J Cancer 33 1216 1220
9. S Carraro EL Roca C Cartelli L Rafailovici S Castillo Odena E Wasserman U Gualdrini E Huertas M Barugel G Ballarino MC Rodriguez G Masciangioli 2002 Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study Int J Radiat Oncol Biol Phys 54 397 402
10. V Chiarion-Sileni L Corti A Ruol R Innocente C Boso P Del Bianco J Pigozzo R Mazzarotto O Tomassi E Ancona 2007 Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer Br J Cancer 96 432 438
11. A Cividalli F Ceciarelli E Livdi P Altavista G Cruciani P Marchetti DT Danesi 2002 Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule Int J Radiat Oncol Biol Phys 52 1092 1098
12. JS Cooper MD Guo A Herskovic JS Macdonald JA Martenson Jr M Al-Sarraf R Byhardt AH Russell JJ Beitler S Spencer SO Asbell MV Graham LL Leichman 1999 Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01) Radiation Therapy Oncology Group JAMA 281 1623 1627
13. DP Cronin-Fenton L Sharp AE Carsin H Comber 2007 Patterns of care and effects on mortality for cancers of the oesophagus and gastric cardia: a population-based study Eur J Cancer 43 565 575
14. D Cunningham N Starling S Rao T Iveson M Nicolson F Coxon G Middleton F Daniel J Oates AR Norman 2008 Capecitabine and oxaliplatin for advanced esophagogastric cancer N Engl J Med 358 36 46
15. A de Gramont A Figer M Seymour M Homerin A Hmissi J Cassidy C Boni H Cortes-Funes A Cervantes G Freyer D Papamichael N Le Bail C Louvet D Hendler F de Braud C Wilson F Morvan A Bonetti 2000 Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938 2947
16. JM Extra M Espie F Calvo C Ferme L Mignot M Marty 1990 Phase I study of oxaliplatin in patients with advanced cancer Cancer Chemother Pharmacol 25 299 303
17. G Freyer N Bossard P Romestaing F Mornex O Chapet V Trillet-Lenoir JP Gerard 2001 Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial J Clin Oncol 19 2433 2438
18. V Gebski B Burmeister BM Smithers K Foo J Zalcberg J Simes 2007 Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol 8 226 234
19. JI Geh 2002 The use of chemoradiotherapy in oesophageal cancer Eur J Cancer 38 300 313
20. Greene FL, Page DL, Fleming ID et al (eds) (2002) American Joint Committee on Cancer Staging Manual, 6th edn. Springer, Philadelphia
21. A Herskovic K Martz M al-Sarraf L Leichman J Brindle V Vaitkevicius J Cooper R Byhardt L Davis B Emami 1992 Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus N Engl J Med 326 1593 1598
22. WM Hryniuk M Goodyear 1990 The calculation of received dose intensity J Clin Oncol 8 1935 1937
23. A Jatoi BR Murphy NR Foster DA Nikcevich SR Alberts JA Knost TR Fitch KM Rowland Jr 2006 Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group Ann Oncol 17 29 34
24. DP Kelsen R Ginsberg TF Pajak DG Sheahan L Gunderson J Mortimer N Estes DG Haller J Ajani W Kocha BD Minsky JA Roth 1998 Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer N Engl J Med 339 1979 1984
25. NI Khushalani CG Leichman G Proulx H Nava L Bodnar D Klippenstein A Litwin J Smith E Nava L Pendyala P Smith W Greco J Berdzik H Douglass L Leichman 2002 Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer J Clin Oncol 20 2844 2850
26. K Knyrim HJ Wagner N Bethge M Keymling N Vakil 1993 A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer N Engl J Med 329 1302 1307
27. SC Malaisrie WL Hofstetter AM Correa JA Ajani RR Komaki DC Rice AA Vaporciyan GL Walsh JA Roth TT Wu SG Swisher 2006 The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma Cancer 107 967 974
28. C Mariette L Finzi G Piessen I Van Seuningen JP Triboulet 2005 Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma World J Surg 29 39 45
29. C Mariette JP Triboulet 2006 Should resectable esophageal cancer be resected? Ann Surg Oncol 13 447 449
30. AM Mauer EH Kraut SA Krauss RH Ansari K Kasza L Szeto EE Vokes 2005 Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus Ann Oncol 16 1320 1325
31. J Maurel A Cervantes C Conill R Salazar M Martin-Richard M Pera H Manzano I Chirivella R Gallego X Marfa 2005 Phase I trial of oxaliplatin in combination with cisplatin, protected-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma Int J Radiat Oncol Biol Phys 62 91 96
32. BM O'Connor MK Chadha A Pande JC Lombardo CE Nwogu HR Nava G Yang MM Javle 2007 Concurrent oxaliplatin, 5-fluorouracil, and radiotherapy in the treatment of locally advanced esophageal carcinoma Cancer J 13 119 124
33. MB Polee WC Hop TC Kok FA Eskens ME van der Burg TA Splinter PD Siersema HW Tilanus G Stoter A van der Gaast 2003 Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy Br J Cancer 89 2045 2050
34. P Rohatgi SG Swisher AM Correa TT Wu Z Liao R Komaki GL Walsh AA Vaporciyan DC Rice JA Roth JA Ajani 2005 Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response Cancer 104 2365 2372
35. JR Siewert K Ott 2007 Are squamous and adenocarcinomas of the esophagus the same disease? Semin Radiat Oncol 17 38 44
36. JR Siewert HJ Stein M Feith BL Bruecher H Bartels U Fink 2001 Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1, 000 consecutive resections at a single center in the Western world Ann Surg 234 360 367 discussion 368-9
37. M Stahl M Stuschke N Lehmann HJ Meyer MK Walz S Seeber B Klump W Budach R Teichmann M Schmitt G Schmitt C Franke H Wilke 2005 Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus J Clin Oncol 23 2310 2317
38. SG Urba MB Orringer A Turrisi M Iannettoni A Forastiere M Strawderman 2001 Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 19 305 313
39. P Viklund M Lindblad M Lu W Ye J Johansson J Lagergren 2006 Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden Ann Surg 243 204 211
40. ZF Xiao ZY Yang YJ Miao LH Wang WB Yin XZ Gu DC Zhang KL Sun GY Chen J He 2005 Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases Int J Radiat Oncol Biol Phys 62 82 90
41. Z Zhang Z Liao J Jin J Ajani JY Chang M Jeter T Guerrero CW Stevens S Swisher L Ho J Yao P Allen JD Cox R Komaki 2005 Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy Int J Radiat Oncol Biol Phys 61 656 664